Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Tuesday Mar 22, 2022
Tuesday Mar 22, 2022
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team discuss latest guideline recommendations for HFrEF therapies and how new and emerging therapies may be incorporated into clinical practice, now and in the future
The multidisciplinary team
- Cardiology nurse specialist: Dr Carol Wade, Baltimore, USA
- Cardiologist: Dr Akshay Desai, Boston, USA
- Primary care physician: Prof. Ahmet Fuat, Darlington, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
Tuesday Mar 22, 2022
Tuesday Mar 22, 2022
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss established therapies for HFrEF and key efficacy and safety considerations for new and emerging therapies
The multidisciplinary team
- Primary care physician: Prof. Ahmet Fuat, Darlington, UK
- Cardiologist: Dr Akshay Desai, Boston, USA
- Patient: Ms Sarah Worsnop, Hull, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
Tuesday Mar 22, 2022
Tuesday Mar 22, 2022
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss the role of the multidisciplinary team in managing patients with HF
The multidisciplinary team
- Cardiologist: Dr Akshay Desai, Boston, USA
- Primary care physician: Prof. Ahmet Fuat, Darlington, UK
- Cardiology nurse specialist: Dr Carol Wade, Baltimore, USA
- Patient: Ms Sarah Worsnop, Hull, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchIMMUNOLOGY
Listen in as a dermatologist, a dermatopathologist, a radiation oncologist and a head and neck surgeon discuss the role of the multidisciplinary team in the care of patients with CSCC and how effective collaboration can improve outcomes for these patients.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchIMMUNOLOGY
Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.
The multidisciplinary team
- Dermato-oncologist: Dr Joël Claveau, Canada
- Dermatologist: Prof. Caroline Robert, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchIMMUNOLOGY
Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.
The multidisciplinary team
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchIMMUNOLOGY
Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchONCOLOGY
Listen in as a dermatologist, a dermatopathologist, a radiation oncologist and a head and neck surgeon discuss the role of the multidisciplinary team in the care of patients with CSCC and how effective collaboration can improve outcomes for these patients.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchONCOLOGY
Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.
The multidisciplinary team
- Dermato-oncologist: Dr Joël Claveau, Canada
- Dermatologist: Prof. Caroline Robert, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchONCOLOGY
Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.
The multidisciplinary team
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management